Lorem ipsum dolor sit amet, consectetur badipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
The Capital – A Wing, 1802, 18th Floor, Plot No. C-70, G Block, Bandra Kurla Complex,
Bandra (East), Mumbai – 400 051, India.
® Trademark Proprietor – Pfizer Products Inc., USA Licensed User – Pfizer Limited, India.
To view the summary of prescribing information for LORBRIQUA®, please
click here.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.
Full prescribing information available on request.
ALK, anaplastic lymphoma kinase; ALK+, anaplastic lymphoma kinase-positive; CNS, central nervous system; NCCN, National Comprehensive Cancer Network; NSCLC, non-small cell lung cancer.
References:
Please click the Prescribing Information link to view the safety and adverse events information of LORBRIQUA®.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.